Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
French and Malaysian authorities are investigating Grok for generating sexualized deepfakes - 2Netanyahu expects Iran's leadership to fall
- 3Phonetic Associations: A Survey of \Interfacing Worldwide People group\ Language Trade Application
- 4Figurine of a woman and a goose offers peek at prehistoric beliefs
- 5Explainer-What has happened to the damaged spacecraft at China's space station?
- Christmas 2025 skywatching guide: What you can see in the night sky on Dec. 25
- German unemployment rate falls to 6.4%, but 3 million still jobless
- Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
- Pick Your Top Method for starting the Morning
- Which restaurants and fast food chains will be open on Christmas Eve and Christmas Day?
- Hamas demanded displaced Gazans pay rent on beach tents amid torrential downpour, IDF reveals
- Volcanic eruption led to the Black Death, new research suggests
- CDC clarifies stance on vaccines and autism, stating no evidence supports the link
- UK, Canada, Germany, others condemn Israel's West Bank settlement plan
